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Objectives. This study was designed to compare QT dispersion
measured from the standard 12-lead electrocardiogram and 24-h
heart rate variability in patients with vulnerability to either
ventricular tachycardia or ventricular fibrillation after a previous
myocardial infarction.
Background. Increased QT interval dispersion and reduced
heart rate variability have been shown to be associated with
vulnerability to ventricular tachyarrhythmias, but the data have
mainly been pooled from patients with presentation of stable
ventricular tachycardia and ventricular fibrillation.
Methods. QT dispersion and time domain and two-dimensional
vector analysis of heart rate variability were studied in 30
survivors of ventricular fibrillation with a previous myocardial
infarction and with inducible unstable ventricular tachyarrhyth-
mia by programmed electrical stimulation and in 30 postinfarc-
tion patients with clinical and inducible stable monomorphic
sustained ventricular tachycardia. Both of these patient groups
were matched, with respect to age, gender and left ventricular
ejection fraction, with an equal number of postinfarction control
patients without a history of arrhythmic events or inducible
ventricular tachyarrhythmia and arrhythmia-free survival during
a follow-up period of 2 years. Forty-five age-matched healthy
subjects served as normal control subjects.
Results. Standard deviation of all sinus intervals and long-term
continuous RR interval variability analyzed from Poincare´ plots
were reduced in patients with vulnerability to ventricular fibril-
lation (p < 0.001 for both), but not in patients with ventricular
tachycardia (p 5 NS for both), compared with postinfarction
control subjects. Corrected QT (QTc) dispersion was significantly
broader both in patients with ventricular fibrillation (p < 0.001)
and in those with ventricular tachycardia (p < 0.05) than in
matched postinfarction control subjects. Heart rate variability
performed better than QTc dispersion in predicting vulnerability
to ventricular fibrillation.
Conclusions. Increased QT dispersion is associated with vulnera-
bility to both ventricular tachycardia and ventricular fibrillation.
Low heart rate variability is specifically related to susceptibility to
ventricular fibrillation but not to stable monomorphic ventricular
tachycardia, suggesting that the autonomic nervous system modifies
the presentation of life-threatening ventricular arrhythmias.
(J Am Coll Cardiol 1997;30:1331–8)
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Broad QT dispersion (i.e., increased variability in the QT
interval length between the leads of a 12-lead surface electro-
cardiogram [ECG]) reflects differences in the local myocardial
repolarization/recovery times (1–6) and hence the electro-
physiologic environment (substrate) that favors reentry (7–10).
Low heart rate variability, an indicator of abnormal cardiac
autonomic regulation, may condition the heart to a spontane-
ous onset of ventricular tachyarrhythmias but is not a specific
marker of an arrhythmic substrate (11). Both increased QT
dispersion and reduced heart rate variability have been shown
(10,12–14) to be associated with vulnerability to life-
threatening ventricular arrhythmias in patients with a previous
myocardial infarction. However, the data have mainly been
pooled from patients with presentation of stable ventricular
tachycardia and ventricular fibrillation, without regard for
possible differences in the underlying pathophysiologic mech-
anisms of the two arrhythmias. In the present work, we
compared QT dispersion and heart rate variability between
groups with different clinical and electrophysiologic presenta-
tions of ventricular tachyarrhythmia after a previous myocar-
dial infarction.
Methods
Patients. The study included 94 consecutive patients with
coronary artery disease admitted to the Oulu University Hos-
pital (n 5 88) or the Miami University Medical Center (n 5 6)
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because of ventricular tachycardia or ventricular fibrillation
and 70 consecutive patients with a previous myocardial infarc-
tion referred to the Oulu University Hospital for coronary
angiography but with no history of ventricular tachyarrhythmia
(postinfarction control subjects). Of the 94 patients with a
history of arrhythmic events, 59 underwent resuscitation for
ventricular fibrillation, and of these 59 patients ventricular
fibrillation (n 5 8) or hemodynamically unstable ventricular
tachycardia (polymorphic ventricular tachycardia in 11, ven-
tricular flutter in 11) was induced during programmed electri-
cal stimulation in 30. Thirty-five of these 94 patients presented
with hemodynamically stable ventricular tachycardia, and sta-
ble monomorphic ventricular tachycardia during programmed
electrical stimulation was induced in 30 of these 35 patients.
Patients with clinical presentation of ventricular fibrillation
and inducible unstable ventricular tachyarrhythmia and those
with clinical and inducible monomorphic sustained ventricular
tachycardia were matched with respect to age, left ventricular
ejection fraction and gender with corresponding control postin-
farction patients without inducible nonsustained or sustained
ventricular tachycardia during programmed electrical stimula-
tion and without death or an occurence of ventricular tachy-
arrhythmia during the follow-up period of 2 years. The
matched variables were scaled as follows: 1) age between 45
and 50 years, 50 and 55 years, 55 and 60 years, 60 and 65 years,
65 and 70 years and .70 years; 2) left ventricular ejection
fraction ,20%, 20% to 25%, 25% to 30%, 30% to 35%, 35%
to 40%, 40% to 45%, 45% to 50% or .50%; and 3) male or
female gender. Each patient in both arrhythmia groups was
matched 1:1 with a control postinfarction patient according to
these criteria. Forty-five age- and gender-matched healthy
subjects (mean [6SD] age 60 6 12 years; 40 men, 5 women)
served as normal control subjects and were selected from
among subjects who were participating in a larger trial com-
paring the characteristics of hypertensive and normotensive
subjects, the latter group having been randomly selected from
the general population of Oulu on the basis of their social
security numbers. They had all undergone a complete physical
examination and had a medical history that revealed no
cardiovascular disease or medication. They also had normal
blood pressure levels; normal 12-lead ECG and M-mode,
two-dimensional and doppler echocardiographic results; and
none had evidence of ischemic ST segment depression on
exercise electrocardiography. Patients and healthy control
subjects gave their informed consent, and the tests were
approved by the ethics committee of the University of Oulu.
All patients with and without arrhythmias were examined
by cardiac catheterization, coronary angiography and pro-
grammed electrical stimulation. A 12-lead surface ECG was
recorded in each patient at a 50-mm/s paper speed. The clinical
and angiographic characteristics of the postinfarction patients
are presented in Table 1.
Electrophysiologic and angiographic studies. Electro-
physiologic testing included incremental ventricular pacing and
programmed ventricular stimulation using up to three extra-
stimuli and two basic drive cycle lengths (600 and 400 ms) from
the right ventricular apex and the outflow tract. The protocol
of the electrophysiologic testing and the definitions of induc-
Abbreviations and Acronyms
ECG 5 electrocardiogram
JT interval 5 interval from the J point to the end
of the T wave
JTc interval 5 corrected JT interval
QTa interval 5 QT apex interval (interval from
onset of the QRS complex to the
apex of the T wave)
QTac interval 5 corrected QTa interval
Te interval 5 T end interval (interval from the
apex of the T wave to its end)
Tec interval 5 corrected Te interval
Table 1. Clinical and Angiographic Characteristics of
Study Patients*
VF Group
(n 5 30)
VF Control
Group
(n 5 30)
VT Group
(n 5 30)
VT Control
Group
(n 5 30)
Age (yr) 64 6 6 61 6 6 64 6 7 61 6 5
Men/women 26/4 26/4 27/3 27/3
Time since prior MI (mo) 22 6 30 35 6 44 39 6 46 37 6 42
Medication
ACE inhibitor 6 6 6 4
Ca blocker 4 9 3 7
Beta-blocker 17 21 11† 20
Digitalis 15 10 10 9
Diuretic drugs 14 16 7† 15
NYHA functional class
I 2 0 2 0
II 10 13 15 13
III 16 17 13 16
IV 2 0 0 0
Coronary angiography
1 VD 3 4 9 5
2 VD 11 7 13† 6
3 VD 15 19 8† 18
LVEF (%) 40 6 9 42 6 6 42 6 11 41 6 6
Location of MI
Ant 15 15 16 13
Inf 6 5 10 7
Multiple 9 10 4 9
VPD class
1 (,10 VPDs/h) 13 18 20 16
2 (10–30 VPDs/h) 7 6 5 7
3 (.30 VPDs/h) 10 6 5 6
NSVT on Holter 6 6 4 6
*All with a previous myocardial infarction (MI). †p , 0.05, arrhythmic group
versus corresponding control group. Data presented are mean value 6 SD or
number of patients. ACE 5 angiotensin-converting enzyme; Ant 5 anterior;
Ca 5 calcium; Inf 5 inferior; LVEF 5 left ventricular ejection fraction; NSVT 5
nonsustained ventricular tachycardia; NYHA 5 New York Heart Association;
VD 5 vessel disease; VF Control Group 5 matched control subjects for the VF
Group (ventricular fibrillation [VF]) and inducible ventricular fibrillation or
unstable ventricular tachycardia [VT]); VPD 5 ventricular premature depolar-
ization; VT Control Group 5 matched control subjects for the VT Group
(clinical and inducible stable monomorphic ventricular tachycardia).
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ible arrhythmias have been described previously (15). If ven-
tricular tachyarrhythmia was inducible with three extrastimuli
and the shortest coupling interval was ,200 ms, the arrhythmia
was classified as nonclinical. Left-sided cardiac catheterization
was performed using the Judkins technique. Selective coronary
artery angiograms were obtained in multiple projections, in-
cluding caudal and cranial views, and a lumen narrowing
.50% was considered significant stenosis.
Measurement of QT interval and dispersion. The QT and
QT apex (QTa) intervals and the QRS complex duration were
measured at each lead of the 12-lead surface ECG for two
consecutive cycles. The details of the method of measuring the
dispersion of intervals have been previously described (10).
The QTa intervals were measured from the onset of the QRS
complex to the apex of the T wave. QRS duration was
measured from the beginning of the QRS complex to its end.
The T end (Te) interval (from the apex of the T wave to its
end) was calculated from the equation Te 5 QT 2 QTa and
the JT interval (from the J point to the end of the T wave) from
the equation JT 5 QT 2 QRS. The measurements were
performed manually by an experienced observer (J.S.P.) who
had no knowledge of the clinical data of the patients. The QT,
QTa, Te and JT dispersions were defined as the differences
between the maximal and minimal QT, QTa, Te and JT values,
respectively, and the mean value of two consecutive cycles was
calculated. The Bazett formula was used to obtain heart
rate-corrected values of the QT intervals and the QT, QTa, Te
and JT dispersions. An ECG was recorded 2 to 7 days after the
arrhythmic event, before the electrophysiologic studies. Pa-
tients were excluded from the QT dispersion analysis if no
technically relevant ECG had been recorded during that
period. ECGs were excluded if the rhythm was paced, atrial
fibrillation or atrial flutter occurred, or if the QT interval could
not be accurately measured on at least six leads.
Analysis of heart rate variability. The patients were exam-
ined with an ambulatory ECG recorder for a 24-h period
(Dynacord Holter Recorder, model 420, DM Scientific). The
ECG data were transferred from the Del Mar Avionics scanner
(model 500) to a microcomputer for analysis of heart rate
variability by a method described in detail previously (16,17).
Premature beats and noise were excluded both automatically
and manually, and the gaps were then refilled with an average
value. Patients with segments with ,85% qualified beats were
excluded from the analysis.
Heart rate variability was analyzed by a measurement of the
standard deviation of all sinus intervals from the 24-h period
and by measuring separately the instantaneous and continuous
RR interval variability by using a two-dimensional vector
analysis technique recently described in detail (18). Briefly, the
Poincare´ plot is a diagram in which each RR interval of a
tachogram is plotted as a function of the previous RR interval
for a predetermined segment length. The program used in
these experiments provides a graphic display of the plots and a
quantitative analysis of the shape of the scattergrams. The
scattergrams of successive RR intervals were plotted for the
24-h period throughout the 24-h recording period. The stan-
dard deviation of instantaneous RR interval variability and the
standard deviation of long-term continuous RR interval vari-
ability were then analyzed (18). The standard deviation of all
sinus intervals and the standard deviation of long-term contin-
uous RR interval variability were calculated as absolute values
and in normalized units obtained by dividing the absolute value
by the average RR interval and multiplying by 1,000.
Statistical methods. A nonparametric independent sample
t test (Mann-Whitney) was used to estimate the differences in
the QT and heart rate variability values between the patient
groups and the matched postinfarction control group, and the
Kruskal-Wallis test was used to compare patients with different
clinical presentations of arrhythmia. Analysis of covariance
was used for comparison of corrected QT (QTc) dispersion
and heart rate variability between the ventricular tachycardia
group and the matched postinfarction control group adjusting
for baseline differences in clinical and angiographic variables.
When analyzing the sensitivity, specificity and accuracy of the
different measures of heart rate variability and QTc dispersion
in identifying the patients with vulnerability to ventricular
fibrillation or ventricular tachycardia, the 95% percentiles of
the heart rate variability values and QTc dispersion obtained
from the healthy subjects were used as cutoff points for
abnormal heart rate variability and QTc dispersion, respec-
tively. p , 0.05 was considered significant. Receiver operating
characteristic curves, which show sensitivity as a function of the
complement of specificity, were calculated using GraphROC
software (19).
Results
Clinical and angiographic data. Clinical and angiographic
data for the study patients are presented in Table 1. Age,
gender, time from previous myocardial infarction, left ventric-
ular ejection fraction and infarct location did not differ signif-
icantly between the arrhythmia groups and the corresponding
matched postinfarction control group. The patients in the
ventricular tachycardia group used beta-adrenergic blocking
agents and diuretic drugs less often than the matched postin-
farction control group. Otherwise, medication did not differ
significantly between the arrhythmia groups and the corre-
sponding control group. The frequency of ventricular prema-
ture depolarizations or the occurrence of nonsustained ven-
tricular tachycardia on the Holter recordings did not differ
significantly between the arrhythmia groups and the corre-
sponding postinfarction control group.
Heart rate variability. In the group of 45 healthy subjects,
the standard deviation of all sinus intervals was (mean 6 SD)
150 6 40 ms (range 79 to 228, cutoff point 94), and the
standard deviation of long-term continuous RR interval vari-
ability was 125 6 38 ms (range 62 to 223, cutoff point 70). The
standard deviations of all sinus intervals and long-term contin-
uous RR interval variability were significantly lower in the
ventricular fibrillation group than in the postinfarction control
group (Table 2). The 24-h mean RR interval was also shorter
in the ventricular fibrillation group than in the postinfarction
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control group, but the differences in the standard deviation of
all sinus intervals and the standard deviation of long-term
continuous RR interval variability remained significant after
normalization of the values with the average heart rate. None
of the measures of heart rate variability differed between the
patients with stable ventricular tachycardia and the postinfarc-
tion control subjects (Table 2), even after adjusting for beta-
blocker and diuretic medication and angiographic severity of
coronary artery disease. The standard deviations of all sinus
intervals and long-term continuous RR interval variabilities for
the original study cohort according to the presenting clinical
arrhythmia are shown in Table 3.
QT dispersion and QT intervals. In the group of 45 healthy
subjects, the QTc dispersion was 56 6 19 ms (range 25 to 101,
cutoff point 94). All the measures of QTc dispersion were
significantly broader in the patients with ventricular fibrillation
than in the postinfarction control subjects. The QTc maximal
and minimal intervals were longer and the RR interval shorter
in the ventricular fibrillation group than in the postinfarction
control group (Table 4).
QTc and corrected QTa (QTac) dispersion were signifi-
cantly longer in the ventricular tachycardia group than in the
postinfarction control group, but the differences in corrected
JT (JTc) dispersion (p 5 0.085) and corrected Te (Tec)
dispersion (p 5 0.15) did not reach statistical significance. The
maximal QTc interval was longer, but the RR interval was
similar, in patients with stable ventricular tachycardia than in
the corresponding matched postinfarction control subjects
(Table 4). After adjustment for differences in use of beta-
blocker and diuretic medication and severity of coronary artery
disease between the ventricular tachycardia group and the
matched postinfarction control group, QTc dispersion still
differed (F 5 5.165, p , 0.05).
There was no significant correlation between QTc disper-
sion and the standard deviation of long-term continuous RR
interval variability (r 5 0.11, p 5 NS) or QTc dispersion and
the standard deviation of all sinus intervals (r 5 0.13, p 5 NS).
The values of QTc dispersion for the original study cohort
according to the presenting clinical arrhythmia are shown in
Table 3.
Accuracy of QTc dispersion and heart rate variability in
predicting susceptibility to ventricular tachyarrhythmias.
The sensitivity, specificity and positive and negative predictive
accuracy of QTc dispersion, the standard deviation of long-
term continuous RR interval variability and the standard
deviation of all sinus intervals in predicting vulnerability to
ventricular fibrillation and ventricular tachycardia are shown in
Table 5. The specificity of the standard deviation of long-term
continuous RR interval variability was higher than that of QTc
dispersion in identifying the patients with vulnerability to
ventricular fibrillation, but QTc dispersion was more accurate
than the standard deviation of long-term continuous RR
interval variability or the standard deviation of all sinus
intervals in identifying vulnerability to ventricular tachycardia
(Table 5). The standard deviation of long-term continuous RR
interval variability was more specific than the standard devia-
Table 2. Heart Rate Variability
VF Group
(n 5 29)
VF Control
Group
(n 5 29)
VT Group
(n 5 29)
VT Control
Group
(n 5 29)
Avg RRi (ms) 834 6 120* 954 6 146 1,009 6 159 955 6 146
SDNN (ms) 68 6 26† 110 6 27 108 6 37 103 6 22
SDNNn 81 6 24† 115 6 26 106 6 33 107 6 18
SD1 (ms) 17 6 10‡ 23 6 14 22 6 11 23 6 14
SD2 (ms) 55 6 22† 99 6 28 96 6 35 95 6 28
SD2n 66 6 23† 102 6 20 95 6 32 98 6 19
*p , 0.01, †p , 0.001, ‡p , 0.05, arrhythmic group versus corresponding
control group. Data presented are mean value 6 SD. Avg RRi 5 average RR
interval; SDNN 5 standard deviation of sinus RR intervals analyzed from 24-h
Holter recordings; SDNNn 5 SDNN divided by the average RR interval and
multiplied by 1,000; SD1 5 standard deviation of instantaneous RR interval
variability; SD2 5 standard deviation of long-term continuous RR interval
variability (see Methods for details); SD2n 5 SD2 divided by the average RR
interval and multiplied by 1,000; other abbreviations as in Table 1.
Table 3. Heart Rate Variability and QTc Dispersion for the
Original Study Cohort According to Presenting Clinical Arrhythmia*
VF VT No VT p Value†
SD2 (ms) 74 6 30‡ 91 6 36 100 6 32 , 0.001
(n 5 58) (n 5 31) (n 5 58)
SDNN (ms) 86 6 33§ 104 6 37 108 6 30 0.001
(n 5 59) (n 5 32) (n 5 60)
QTc dis (ms) 98 6 40§ 98 6 40\ 70 6 32 , 0.001
(n 5 47) (n 5 29) (n 5 49)
*See Methods. †Kruskal-Wallis test. ‡p , 0.001, §p , 0.01, patients with
clinical presentation of ventricular fibrillation (VF) versus those with no ventric-
ular tachyarrhythmias (Bonferroni post hoc test). \p , 0.01, patients with clinical
presentation of sustained stable ventricular tachycardia (VT) versus those with
no ventricular tachyarrhythmias (Bonferonni post hoc test). Data presented are
mean value 6 SD. QTc dis 5 corrected QT interval dispersion; other abbrevi-
ations as in Tables 1 and 2.
Table 4. RR Interval, QT Intervals and QT Dispersion
VF Group
(n 5 23)
VF Control
Group
(n 5 27)
VT Group
(n 5 26)
VT Control
Group
(n 5 26)
RRi 833 6 115* 967 6 210 1022 6 210 979 6 191
QTc max 520 6 51† 454 6 45 487 6 48* 460 6 46
QTc min 406 6 34* 386 6 27 388 6 32 388 6 29
QTc dis 113 6 42† 68 6 32 99 6 43* 72 6 32
QT dis 103 6 37‡ 67 6 32 98 6 43* 71 6 32
QTac dis 95 6 39‡ 62 6 34 79 6 32* 62 6 34
QTa dis 86 6 35* 61 6 33 79 6 32* 62 6 33
Tec dis 68 6 35* 44 6 19 53 6 22 45 6 18
Te dis 62 6 32 43 6 19 54 6 24 44 6 18
JTc dis 117 6 38† 73 6 31 104 6 44 83 6 34
JT dis 106 6 35† 71 6 32 104 6 45 81 6 35
*p , 0.05, †p , 0.001, ‡p , 0.01, arrhythmic group versus corresponding
control group. Data presented are mean value 6 SD (ms). dis 5 dispersion;
JTc 5 corrected JT interval; QTc max 5 maximal corrected QT interval; QTc
min 5 minimal corrected QT interval; QTa 5 QT apex interval; QTac 5
corrected QT apex interval; Te 5 T end interval; Tec 5 corrected T end interval;
other abbreviations as in Tables 1 and 2.
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tion of all sinus intervals in predicting vulnerability to ventric-
ular fibrillation (Table 5) because of complex Poincare´ plots of
some arrhythmic patients, resulting in high standard deviation
of all sinus intervals but not of long-term continuous RR
interval variability analyzed from the Poincare´ plots. The
receiver operating characteristic curves also show that the
standard deviation of long-term continuous RR interval vari-
ability performed better than QTc dispersion in predicting
vulnerability to ventricular fibrillation (Fig. 1), but QTc disper-
sion was better than the standard deviation of long-term
continuous RR interval variability in predicting vulnerability to
ventricular tachycardia at all sensitivity and specificity levels
(Fig. 2).
Discussion
The results of the present study, which was specifically
designed to differentiate between patients with clinical and
electrophysiologic presentation of stable monomorphic ven-
tricular tachycardia or ventricular fibrillation and carefully
matched postmyocardial infarction patients without arrhyth-
mic propensity, showed that QT interval dispersion is in-
creased in patients with vulnerability to both stable and
unstable arrhythmia, but low heart rate variability is observed
only in patients with ventricular fibrillation versus matched
postinfarction patients. In previous studies (10,13,14,20–23),
measurements of QT interval dispersion from surface ECGs
and heart rate variability from Holter recordings have pro-
vided important prognostic information after myocardial in-
farction. However, significant overlapping in the measures of
QT dispersion and heart rate variability has been observed
between patients with and without susceptibility to ventricular
tachyarrhythmias, and the positive predictive accuracy of these
noninvasive measures in predicting arrhythmic events has been
relatively low (10–14,23). Both cross-sectional and follow-up
studies have used mixed patient populations and definitions of
arrhythmic events by including pooled data from patients with
presentation of stable monomorphic ventricular tachycardia
and ventricular fibrillation. However, there is evidence to
suggest that the mechanisms of initiation and perpetuation of
these arrhythmias may differ significantly, and the data support
the assumption that the electrophysiologic substrate differs
between patients with ventricular tachycardia and ventricular
fibrillation (24,25). There is also evidence to suggest that
patients presenting with stable sustained ventricular tachycar-
dia are less likely to experience a lethal recurrence of arrhyth-
mia than are patients presenting with ventricular fibrillation
(26,27) and that the risk of sudden death among ventricular
tachycardia patients is low (28).
Heart rate variability and vulnerability to ventricular
tachyarrhythmias. In contrast to the patients with vulnerabil-
ity to ventricular fibrillation, the patients presenting with stable
monomorphic ventricular tachycardia did not show reduced
heart rate variability compared with the postinfarction patients
without arrhythmic propensity. Farrell et al. (29) reported that
patients with inducible monomorphic ventricular tachycardia
after an acute myocardial infarction have reduced baroreflex
sensitivity and heart rate variability. These results are not
comparable to the present findings because the substrate and
the triggers of ventricular tachyarrhythmias may be different in
patients with subacute and remote myocardial infarction. The
present data suggest that neurohumoral or other factors
Table 5. Sensitivity, Specificity and Positive and Negative Predictive
Accuracy of QTc Dispersion and Heart Rate Variability in
Predicting Vulnerability to Ventricular Tachyarrhythmias
QTc Dis SD2 SDNN
VF
Sens (%) 65 (49) 83 (52) 90 (64)
Spec (%) 81 (84) 93 (90) 60 (58)
PPV (%) 75 (74) 92 (83) 69 (60)
NPV (%) 73 (63) 85 (66) 86 (62)
VT
Sens (%) 46 (45) 29 (39) 31 (41)
Spec (%) 77 (84) 90 (90) 52 (58)
PPV (%) 67 (62) 73 (67) 39 (34)
NPV (%) 59 (72) 57 (74) 43 (65)
Values $94, #70 and #94 ms were considered abnormal for QTc dispersion,
SD2 and SDNN, respectively. Data presented are values calculated for study
groups (original study cohort according to the presenting clinical arrhythmia).
NPV 5 negative predictive value; PPV 5 positive predictive value; Sens 5
sensitivity; Spec 5 specificity; other abbreviations as in Tables 1 to 3.
Figure 1. Receiver operating characteristic curves for SD2 (standard
deviation of long-term continuous heart rate variability) and QTc
dispersion in differentiating between postinfarction patients with a
clinical presentation of ventricular fibrillation and with inducible
sustained unstable ventricular tachyarrythmia during programmed
electrical stimulation and the postinfarction patients without history of
ventricular tachyarrythmia and without inducible nonsustained or
sustained ventricular tachyarrythmia during programmed electrical
stimulation. AUC 5 area under the curve.
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resulting in low heart rate variability may modify the clinical
and electrophysiologic presentation of ventricular tachyar-
rhythmias in patients with a remote myocardial infarction.
Reduced long-term, continuous RR interval variability was a
specific finding in postinfarction patients with clinical ventric-
ular fibrillation and inducible unstable ventricular tachyar-
rhythmia, supporting the notion that abnormal autonomic
balance favors vulnerability to ventricular fibrillation or unsta-
ble ventricular tachyarrhythmia, or both.
Various methods of analyzing heart rate variability have
been used in previous cross-sectional and follow-up studies
(12–14) to predict propensity for ventricular tachyarrhythmias.
Two-dimensional vector analyses of Poincare´ plots can sepa-
rately quantify the instantaneous and continuous long-term
RR interval variabilities. Recently, reduced long-term contin-
uous RR interval variability was observed (18) to precede the
spontaneous onset of ventricular tachyarrhythmia and was also
the most specific noninvasive marker for vulnerability to
ventricular fibrillation in the present study. Quantitative anal-
ysis of long-term RR interval variability from the Poincare´
plots is a more specific assessment of arrhythmic risk because
some patients with vulnerability to life-threatening arrhythmias
present with complex plots with relatively higher values for
standard deviation of all sinus intervals than for standard
deviation of long-term continuous RR interval variability.
Similar complex plots have recently been observed (30) to
predict sudden death in patients with heart failure. Concurrent
with previous observations (31), the average heart rate was
faster in the ventricular fibrillation group than in the control
group. However, the difference in heart rate variability re-
mained significant after correction for heart rate, confirming
that an analysis of heart rate variability gives more specific
information on the risk for fatal arrhythmia than does the
average 24-h heart rate. There were some differences in
medication between the ventricular tachycardia group and the
matched control group (i.e., in beta-blockers, which may
potentially influence heart rate variability). However, previous
data (32) suggest that beta-blockers increase (not reduce)
heart rate variability in patients with coronary artery disease.
Thus, the results of the present study concerning the reduced
heart rate variability in the ventricular fibrillation group but
not in the ventricular tachycardia group cannot be explained by
the differences in beta-blocker medication.
QT dispersion and vulnerability to ventricular tachyar-
rhythmias. The mechanism of ventricular tachycardia origi-
nating in chronic myocardial infarction has been shown to be
reentry (33–37). The role of increased dispersion of repolar-
ization in the genesis of ventricular fibrillation has also been
generally recognized (7,38–40), and infarct scar and reentrant
circuits serve as fixed substrates in the pathogenesis of sus-
tained monomorphic ventricular tachycardia (41). Strong evi-
dence supports the hypothesis that dispersion of refractoriness
and repolarization provides a pathophysiologic basis for reen-
try (7–9,42,43). Furthermore, QT dispersion has been demon-
strated (1–6) to reflect the dispersion of recovery times and
repolarization. Thus, increased QT dispersion indicates the
presence of a substrate for ventricular tachyarrhythmias, most
obviously by a reentry mechanism. In accordance with these
observations, the present cross-sectional study showed that
among patients with a previous myocardial infarction, the
patient groups with different presentations of ventricular
tachyarrhythmia had broader QT dispersion than those with-
out arrhythmic propensity, indicating the presence of a fixed
arrhythmic substrate for ventricular tachyarrhythmias. In the
present study, heart rate was faster in the ventricular fibrilla-
tion group than in the matched control group. However, QT
dispersion was significantly broader in the ventricular fibrilla-
tion group than in the corresponding control group, even
without correction for heart rate.
Accuracy of QT dispersion and heart rate variability in
predicting vulnerability to ventricular tachyarrhythmias. Pre-
vious follow-up studies (13,14,20,22,23) evaluating the accu-
racy of heart rate variability and QT dispersion as predictors of
arrhythmic death have used different definitions, such as death
within 1 h after the onset of symptoms or a combination of
sudden death and the occurrence of ventricular tachycardia.
However, recent data (44,45) suggest that these definitions
lack specificity in terms of tachyarrhythmic death. Although
complete matching of all variables is difficult in case-control
studies, the present data suggest that analysis of long-term
continuous RR interval variability alone has a high positive
predictive accuracy for detecting vulnerability to unstable
ventricular tachyarrhythmia. QTc dispersion seems to be less
Figure 2. Receiver operating characteristic curves for SD2 (standard
deviation of long-term continuous heart rate variability) and QTc
dispersion in differentiating between postinfarction patients with a
clinical presentation of hemodynamically stable sustained ventricular
tachycardia and with inducible stable sustained monomorphic ventric-
ular tachycardia during programmed electrical stimulation and the
postinfarction patients without history of ventricular tachyarrhythmia
during programmed electrical stimulation. AUC 5 area under the
curve.
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specific because of a notable overlap in individual values
between patients with and without a propensity to ventricular
fibrillation. However, no correlation was observed here be-
tween the measures of heart rate variability and QT dispersion.
It would be important to assess the value of combining these
two easily obtained noninvasive methods in an attempt to
identify the postmyocardial infarction patients at highest risk
for ventricular fibrillation and sudden arrhythmic death and
those who are candidates for prophylactic automatic implant-
able cardioverter-defibrillator therapy in future prospective
studies.
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